Publications by authors named "J Christenson"

Maternal immune activation (MIA), a maternal stressor, increases risk for neuropsychiatric diseases, such as Major Depressive Disorder in offspring. MIA of toll-like receptor 7 (TLR7) initiates an immune response in mother and fetuses in a sex-selective manner. The paraventricular nucleus of the hypothalamus (PVN), a brain region that is sexually dimorphic and regulates hypothalamic-pituitary-adrenal (HPA) stress responses, have been tied to stress-related behaviors (i.

View Article and Find Full Text PDF

Background: Previous studies have reported race-based health disparities in North America. It is unknown if emergency medical service (EMS) treatment of out-of-hospital cardiac arrest (OHCA) varies based on race. We sought to compare markers of resuscitation intensity among different racial groups.

View Article and Find Full Text PDF
Article Synopsis
  • The introduction of high-sensitivity troponin (hsTnT) testing for emergency department patients with cardiac chest pain resulted in a significant reduction in length of stay, decreasing from approximately 464 minutes to 285 minutes.
  • The study included over 5,500 patients with cardiac chest pain, revealing a very low rate of missed major adverse cardiac events (MACE) at just 0.2%, indicating the safety of the new testing method.
  • No changes were observed in admission rates for both cardiac (around 24%) and noncardiac chest pain patients, while noncardiac cases remained stable in length of stay as well, underscoring the specific impact of hsTnT testing on cardiac chest pain
View Article and Find Full Text PDF

Out-of-hospital cardiac arrest (OHCA) is a global health problem affecting approximately 4.4 million individuals yearly. OHCA has a poor survival rate, specifically when unwitnessed (accounting for up to 75% of cases).

View Article and Find Full Text PDF
Article Synopsis
  • TDO2 is expressed at higher levels than IDO1 in triple-negative breast cancer (TNBC).
  • Knocking down TDO2 can trigger an increase in IDO1 as a compensatory response.
  • A new dual inhibitor targeting both TDO2 and IDO1 reduces tryptophan catabolism, inhibits anchorage-independent survival, and decreases invasive capabilities of cancer cells.
View Article and Find Full Text PDF